Multivitamin plus omega-3s may be ‘safe, economical and effective means for lowering diabetes risk’: Study

By Stephen Daniells

- Last updated on GMT

© Getty Images / AndreyPopov
© Getty Images / AndreyPopov

Related tags Omega-3 fatty acids Nutrition Diabetes

People at high risk of developing diabetes may benefits from combined supplementation with multivitamins with omega-3s, according to a new study.

Data published in Journal of Clinical & Translational Endocrinology​ indicated almost half of the participants with prediabetes and diabetes regressed to normal blood sugar levels and control after one year of consuming a specially designed multivitamin and mineral that also contained ingredients such as lutein, lycopene, bilberry extract, resveratrol and a host of other bioactives.

“Our results suggest that a relatively straightforward preventative health program that provides nutritional supplementation may have the potential to reduce the risk of diabetes and improve glycemic status in individuals at risk,” ​wrote the researchers.

“The combination of nutritional supplements taken by the Vital 2 participants was associated with a reduced risk of progressing from normoglycemia to prediabetes and an increased likelihood of a prediabetic participant improving to normoglycemia, changes that were sustained at two years after program entry.”

Study details

The researchers, led by Samantha Kimball from the Pure North S’Energy Foundation in Canada (a not-for-profit wellness program based in Calgary), compared over 1,000 participants in the Pure North program that received vitamin D drops (1,000 IU/drop) plus a limited multivitamin alone (Vital 1) or the vitamin D drops plus a more extensive multivitamin and mineral, plus omega-3 fatty acids (Vital 2). For a detailed breakdown of the two multivitamins please refer to the figure below.

Blood levels of vitamin D (25(OH)D concentrations) increased significantly in both groups over 12 months. On the other hand, only Vital 2 was associated with significant reductions in glycated hemoglobin (HbA1c), which is a marker of long-term presence of excess glucose in the blood, and high-sensitivity C reactive protein (hs-CRP), a marker of inflammation.  were

Vital 1 and 2 formulations
Figure: Vital 1 and Vital 2 multivitamin formulations. Source: Kimball et al., Journal of Clinical & Translational Endocrinology

“At one year, 8% of Vital 2 and 16% of Vital 1 participants progressed from normoglycemia to prediabetes/diabetes, whereas 44% of Vital 2 and 8% of Vital prediabetes/diabetes subjects regressed to normoglycemia,” ​wrote the researchers.

“Vitamin D combined with other nutrients was associated with a reduced risk of progression to diabetes and with an increased rate of reversion to normoglycemia in high risk participants,” ​wrote the researchers.

“The results suggest that nutrient supplementation regimes may provide a safe, economical and effective means for lowering diabetes risk. Further examination of this potential via randomized controlled trials is warranted.”

Source: Journal of Clinical & Translational Endocrinology
Volume 10, Pages 28-35, doi: 10.1016/j.jcte.2017.11.002
“Effect of a vitamin and mineral supplementation on glycemic status: Results from a community-based program”
Authors: S.M. Kimball et al. 

Related news

Related products

show more

Nextida: Precision where it matters

Nextida: Precision where it matters

Content provided by Rousselot | 09-May-2024 | Product Brochure

NEXTIDA™ is an innovative platform of specific collagen peptide compositions with new targeted health benefits. Built and backed by science, Nextida stands...

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 08-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Optimize Nutritional Value with DuraLipo™

Optimize Nutritional Value with DuraLipo™

Content provided by INNOBIO Corporation Limited | 02-May-2024 | White Paper

INNOBIO's DuraLipo™ products encapsulates active ingredients within phospholipids, forming a genuine phospholipid bilayer structure.

Related suppliers

Follow us


View more